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Trends
The identiﬁcation of the ﬁrst mem-
brane-associated NAT, Naa60/NatF,
and the ﬁrst chloroplast NAT, Naa70/
NatG, established new modes of the
NAT machinery in their capacity to
acetylate transmembrane and lumenal
chloroplast proteins, respectively.
The structure of the NatA complex
revealed molecular determinants for
substrate-speciﬁc acetylation, includ-
ing the signiﬁcant impact of the auxiliary
Naa15 on the speciﬁcity of the catalyticReview
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N-terminal (Nt) acetylation is known to be a highly abundant co-translational
protein modiﬁcation, but the recent discovery of Golgi- and chloroplast-resident
N-terminal acetyltransferases (NATs) revealed that it can also be added post-
translationally. Nt-acetylation may act as a degradation signal in a novel branch
of the N-end rule pathway, whose functions include the regulation of human
blood pressure. Nt-acetylation also modulates protein interactions, targeting,
and folding. In plants, Nt-acetylation plays a role in the control of resistance to
drought and in regulation of immune responses. Mutations of speciﬁc human
NATs that decrease their activity can cause either the lethal Ogden syndrome or
severe intellectual disability and cardiovascular defects. In sum, recent advan-
ces highlight Nt-acetylation as a key factor in many biological pathways.Naa10.
Nt-acetylation has been shown to reg-
ulate protein complex stoichiometry
through the Ac/N-end rule pathway,
which has also been connected to
hypertension. Further, a link was estab-
lished between Nt-acetylation and glo-
bal protein folding.
Nt-acetylation has been found to play
essential roles in A. thaliana drought-
stress and immune responses, in C.
elegans development and metabolism,
as well as in human diseases.
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thomas.arnesen@uib.no (T. Arnesen).Your Favorite Protein Is Probably Acetylated at its N-Terminus
N-terminal acetylation (Nt-acetylation), also called N/-acetylation (see Glossary and Figure 1),
is a protein modiﬁcation that is poorly represented in textbooks and, as such, many scientists are
unaware that 80% of all human proteins receive an acetyl group at their N-terminus. Owing to
several recent advances in the ﬁeld, however, there is now a growing interest in this protein
modiﬁcation. Several recent contributions shed light on the molecular mechanisms through
which the N-terminal acetyltransferases (NATs) exert their important biological functions.
This review aims at advancing our current understanding of the protein, cellular, and physiologi-
cal consequences of Nt-acetylation based on a multitude of recent reports. Consequently, it also
highlights the fact that Nt-acetylation can no longer be viewed as an automatic negligible
modiﬁcation, but instead emerges as a crucial component in many biological pathways.
How Many and Which Proteins Are N-Terminally Acetylated?
Nt-acetylation has been established as a highly abundant protein modiﬁcation in eukaryotic cells
[1–4]. In fact, it is so common that it is reasonably safe to presume that your favorite protein is
probably subject to this modiﬁcation. The determinant for undergoing Nt-acetylation is mainly
the identity of the ﬁrst two amino acids at the N-terminus. Several NATs (NatA to NatF in humans)
collectively catalyze Nt-acetylation of a majority (80%) of the different types of N-termini occurring
in the proteome, resulting in the Nt-acetylome (Figure 2A). NatA has speciﬁcity towards A-, S-,
T-, V-, C-, and sometimes G-starting N-termini, whose initiator methionine (iMet) has been
removed by methionine amino peptidases (MetAPs) [2,5]. NatD also acts within the iMet-
processed group; however, it is far more selective because it has only been shown to Nt-
acetylate histones H2A and H4, making its contribution to the Nt-acetylome negligible [6,7].
Those N-termini that retain the iMet are modiﬁed by NatB, NatC, NatE, and NatF. In this group
NatB acetylates Met-’Asx/Glx’-type N-termini (MD-, ME-, MN-, and MQ-starting) [8,9] whereas746 Trends in Biochemical Sciences, September 2016, Vol. 41, No. 9 http://dx.doi.org/10.1016/j.tibs.2016.07.005
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Glossary
GCN5-related N-acetyltransferase
(GNAT) superfamily: protein
superfamily related to general control
nondepressed 5 (GCN5) comprising,
among others, the catalytic N/-
acetyltransferases.
N-terminal acetyltransferase
(NAT): enzyme that catalyzes Nt-
acetylation.
N-terminal acetylation (Nt-
acetylation): also known as N/-
acetylation, this is a protein
modiﬁcation involving the addition of
an acetyl group to the free amino
group (N/-group) of a substrate
protein (Figure 1).
NAA/Naa: N/-acetyltransferase
gene/protein, respectively. Names
given to human N-terminal
acetyltransferases are numerically
organized by acetyltransferase activity
type: NatA activity is mediated by the
catalytic subunit Naa10 and the
auxiliary subunit Naa15, while NatB
activity is mediated by the catalytic
Naa20 and auxiliary Naa25 subunits,
and so on.
Nt-acetylome: the part of the
proteome that is subjected to Nt-
acetylation.
N-terminal
amino group
PolypepdeH HH
H
N N+
CH CH
C
C
C
O
O
O
N
H
N
H
R1 R1
H3C
H3C C
O
S SH CoA CoA
α α
Acetyl-Coenzyme A
N-terminal
acetyltransferase
(NAT)
Polypepde
Figure 1. The Addition of an Acetyl Group to a Protein N-Terminus Is Catalyzed by an N-Terminal
Acetyltransferase (NAT). N-terminal acetylation is a protein modiﬁcation that changes the chemical properties of the
N-terminus by neutralizing its positive charge through the addition of an acetyl group. The reaction is enzymatically catalyzed
by N-terminal acetyltransferases (NATs) that transfer the acetyl group (-COCH3, red) from acetyl-CoA (Ac-CoA) onto the
N/-group (NH3+, yellow) of the very ﬁrst amino acid residue of the substrate protein. This modiﬁcation is often referred to as
N/-acetylation to distinguish it from the acetylation of Ne-groups on lysine side chains.NatC, NatE, and NatF act on Met-’hydrophobic/amphipathic’-type N-termini (ML-, MI-, MF-,
MY-, and MK-starting) [10–15]. The recently identiﬁed plant NatG acetylates M-, A-, S-,
T-starting N-termini, however it lacks a human ortholog [16].
Although proteomic technologies are incapable of directly deﬁning the Nt-acetylation status of
the entire proteome, an estimate of the total Nt-acetylation events is possible by extrapolation of
proteomics data to all Swiss-Prot entries (Figure 2, based on [17]). Through this approach, it is
calculated that the NAT family Nt-acetylates 80% of the human proteome (Figure 2A). This
amount relates to both full and partial Nt-acetylation because many proteins exist as both Nt-
acetylated and unacetylated variants. Hence it is very likely that a given protein, for example your
favorite protein, is subject to Nt-acetylation. In determining the likelihood of a particular protein
being Nt-acetylated based on its two ﬁrst amino acids one can make use of the chart in Figure 2B
where the size of subgroups within each NAT substrate class is shown as well as the frequency
of Nt-acetylation events within the subgroups. If the N-terminus of the protein in question starts
with alanine, which is in the NatA substrate class, there is a 95% chance that it is Nt-acetylated,
but if it starts with valine there is a 80% chance that its N-terminus is unacetylated. NatB is
distinguished in this sense because it has near 100% coverage of the Met-’Asx/Glx’-type N-
termini. The combined action of NatC, E and F within the Met-’hydrophobic/amphipathic’-group
will probably undergo further reﬁnement in substrate speciﬁcity-proﬁling because it acts only on
75% of the sequence-predicted substrates. A recent study on NatF revealed that it has
selectivity for membrane proteins and that the NatF substrate category is enriched for trans-
membrane proteins [17]. This study was also the ﬁrst to investigate the membrane-bound part of
the Nt-acetylome, which was found to be equally large in the amount of proteins Nt-acetylated,
although these were typically Nt-acetylated to a lesser degree, meaning that there were more
partial Nt-acetylation events.
The Enzymes Catalyzing N-Terminal Acetylation
The NAT Compilation
The eukaryotic NAT machinery known to date is composed of seven NATs (NatA–NatG)
(Figure 3) of which ﬁve (NatA–NatE) are present in Saccharomyces cerevisiae (reviewed in
[18,19]), whereas multicellular eukaryotes have a sixth NAT, NatF [15,17], and in addition in the
plant Arabidopsis thaliana a seventh NAT, NatG [16] has been identiﬁed. The eukaryotic NAT
machinery is more complex than that of prokaryotes, which only have three known NATs. It is not
well understood why eukaryotic cells have evolved different NATs. NAT diversiﬁcation couldTrends in Biochemical Sciences, September 2016, Vol. 41, No. 9 747
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Figure 2. Occurrence of N-Terminal Acetylation in the Human Proteome. (A) To visualize the common occurrence of Nt-acetylation and N-terminal
acetyltransferase (NAT) activity, the human proteome is divided into the Nt-acetylome (80%) and the non-Nt-acetylome (20%), and subdivided based on NAT-type
substrate categories to illustrate the contribution by the different NATs. Note that the NAT substrate classes described to date also contain some part of the non-Nt-
acetylome, as indicated by the color-coding. (B) To provide a tool for determining the likelihood that a particular protein N-terminal sequence undergoes Nt-acetylation,
the human proteome was divided into NAT substrate classes with the contribution of different N-termini indicated. The inner pie shows the size of the NAT substrate class;
the middle circle matches the pie in (A) and indicates the amount of Nt-acetylated versus unacetylated proteins within each substrate group; and the outer circle provides
a more detailed overview of the different N-termini constituting a substrate class that can be used to predict the Nt-acetylation status of a given protein. For example,
alanine A-starting proteins constitute the largest subgroup within the NatA-type substrate class, and 95% of A-starting proteins are Nt-acetylated. For NatB, the substrate
category accounts for 21% of the proteome with only 0.2% being unacetylated, allowing the assumption that any MD-, ME-, MN-, MQ-starting protein is Nt-acetylated.
NatC/E/F-type substrates are more difﬁcult to predict based on current substrate proﬁles because this group accounts for 28% of the proteome, but with 7% unmodiﬁed.
ML- is the most common substrate within the NatC/E/F class, and 88% of ML-N-termini are Nt-acetylated. Numbers are based on an estimate of total Nt-acetylation
events made by extrapolation of the most recent proteomics data (also including organellar proteins) [17] to all Swiss-Prot entries based on the occurrence of the ﬁrst two
amino acids. Partial Nt-acetylation is considered as an Nt-acetylation event, meaning that a given protein can exist in both Nt-acetylated and non-Nt-acetylated forms,
referred to as a partially Nt-acetylated protein. Proteome occurrences of partial iMet retention for MA-, MS-, MT-, MG-, and MV- were calculated based on their detection
as iMet-processed/unprocessed. Data were lacking for MW- and MR-starting proteins, and these numbers were inferred based on structural similarity.conceivably have co-evolved with the increasing complexity of the proteome. However, based
on the currently identiﬁed enzymes, NATs did not diverge during the evolution of eukaryotes in
which proteome complexity vastly increased [19]. The more complex eukaryotic NAT machinery
entails a specialization towards different substrate groups that could provide a more ﬂexible
system in terms of regulation. In fact, some examples of upstream regulation of NATs have
recently been uncovered (discussed in following sections). The recently discovered NATs, NatF
targeting transmembrane proteins and NatG targeting chloroplast proteins, are clear examples
of specialization, and likely exist owing to a need for particular subgroups of these substrate
types to be Nt-acetylated.748 Trends in Biochemical Sciences, September 2016, Vol. 41, No. 9
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Figure 3. The N-Terminal Acetyltransferase (NAT) Machinery in Eukaryotic Cells. (A) Subunit composition of the seven currently known eukaryotic NATs, NatA–
NatG. The catalytic subunits (Naa10, Naa20, Naa30, Naa40, Naa50, Naa60, and Naa70) typically associate with up to two auxiliary subunits (Naa15, Naa25, Naa35, and
Naa38) that contribute to activity of the NAT complex through ribosome anchoring and/or substrate speciﬁcity-modulation. Amino acids are coded as follows: p, small; /,
Asx/Glx; f, hydrophobic; W, aromatic; C, aliphatic; [+], positively charged; and x, undetermined. Speciﬁc N-termini of the different NAT classes are shown in Figure 2. (B)
Intracellular distribution of the different NAT complexes from unicellular (yeast) to multicellular (mammals and plants) eukaryotes. While NatA–NatE reside in the cytosol,
the two most recently identiﬁed NATs are organellar. NatF is found in both mammals and plants where it, at least in human cells, associates with the Golgi surface. NatG is
found inside plant chloroplasts. In addition, some of the NAT catalytic subunits appear to localize to the nucleus (e.g., Naa10 and Naa50; not shown).
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NAT activity typically requires a NAT complex in which the catalytic transferase subunit joins up
to two auxiliary subunits that may mediate ribosome anchoring and in some cases contribute to
substrate speciﬁcity (Figure 3A) [20–22]. The NatA complex is formed by the catalytic subunit
Naa10 and the auxiliary subunit Naa15 [5,23]. Naa50 is also attached to the NatA complex
together with HYPK (Huntingtin-interacting protein K) [20,24,25]. Naa50 also forms part of the
NatE complex (together with Naa15 and Naa10), which displays distinct substrate speciﬁcity
and a distinct depletion phenotype compared to NatA [12,14,20,21,26]. NatB is composed of
the catalytic subunit Naa20 and the auxiliary subunit Naa25 [27,28]. The catalytic subunit of
NatC is Naa30, which associates with two noncatalytic subunits, Naa35 and Naa38, of which
Naa35 mediates ribosomal association, whereas the role of Naa38 is less well described
[11,13,22]. For NatD (Naa40), NatF (Naa60), and NatG (Naa70) no auxiliary subunit has been
identiﬁed so far (Figure 3A). Interestingly, a recent study revealed that an N-terminal segment of
Naa40, which is unique compared to the other catalytic Naas, might play a role that is analogous
to the ribosomal-binding auxiliary subunits found in the other NATs [29].
The Workplace of NATs
Most NATs are localized in the cytosol (Figure 3B). NatA–NatE are associated with ribosomes,
where they perform co-translational Nt-acetylation (Figure 3A) [20,22]. In addition, some catalytic
subunits may localize to the nucleus [7,17,23] and Naa10 and Naa50 also display NAT activity in
the absence of the ribosome-anchoring subunit, Naa15, but with altered substrate speciﬁcities
[12,14,17,21]. Given that these NATs also exist in nonribosomal forms, this suggests that NATs
might also act post-translationally [14]. In fact, several internal peptides, produced by post-
translational cleavage in vivo, are Nt-acetylated [30,31] and a speciﬁc example of a protein
undergoing such post-translational processing is actin [32].
Of particular interest are two newly identiﬁed NATs with organellar localization (Figure 3B). NatF is
associated with the Golgi apparatus facing the cytosolic side where it Nt-acetylates transmem-
brane proteins [17]. NatG was identiﬁed as the ﬁrst NAT localized inside an organelle, in this case
in chloroplasts of the plant A. thaliana [16]. These recent studies underpin the post-translational
nature of Nt-acetylation and ﬁnally connect this modiﬁcation to cellular organelles.
Nt-Acetylation from a Structural Viewpoint: A Blueprint
Structural information on the NATs is currently emerging as the crystal structures of several N/-
acetyltransferases and NAT complexes have been solved. The recently developed bisubstrate
analog-based N/-acetyltransferase inhibitors [33] have been useful in some of these structural
studies.
A crystal structure with both subunits of the NatA complex (Naa10 and Naa15) has been solved
(Figure 4A) [21]. The Naa15 subunit consists of 37 /-helices arranged into 13 TPR (tetratri-
copeptide repeat) motifs [21]. These are conserved motifs composed of sequences of 34 amino
acids that generally serve as protein–protein interaction motifs [34]. Some of the TPR motifs in
Naa15 are involved in Naa10 binding [21], and it is likely that they are also crucial for the
associations of Naa15 with Naa50, HYPK, and the ribosome (Figure 3A). The overall tertiary
structure of Naa15 forms a ring-like structure with a cavity into which Naa10 binds (Figure 4A).
The Naa15–Naa10 binding is mainly conducted by a large hydrophobic interface as well as by a
few hydrogen bonds [21].
The catalytic subunits of NATs belong to the GCN5-related N-acetyltransferase (GNAT)
superfamily together with some of the lysine acetyltransferases (KATs). All the NATs share the
structural GNAT-domain (Figure 4B), which is an evolutionarily conserved characteristic of NATs,
as shown by structural analyses of the bacterial NAT RimI [35] and the NAT from the archaea
Sulfolobus solfataricus [36]. The GNAT domain consists of a central acetyl-CoA binding motif750 Trends in Biochemical Sciences, September 2016, Vol. 41, No. 9
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Figure 4. Structural Models of the NatA Complex. (A) Crystal structure of the Schizosaccharomyces pombe yeast
NatA complex showing the interaction between the catalytic subunit Naa10 (cyan) and the auxiliary unit Naa15 (pink). The
semi-transparency of Naa15 shows the insertion of Naa10 into the Naa15 binding cavity. (B) X-ray structure of the GNAT-
fold (cartoon) depicted on Naa10 (surface) showing the positions of the acetyl-CoA binding domain-forming /-helix /3
(yellow) and b-sheets b2 (blue), b3, and b4 (green tones) as well as the peptide substrate-binding pocket-forming N-terminal
/1-loop-/2 (blue/cyan, lower arrow) and the C-terminal b-hairpin of b6-loop-b7 (orange/red, upper arrow). (C) Association
of a bisubstrate analog-based inhibitor with the peptide-acetyl-CoA substrate-binding pockets of the Naa10 monomer
enzyme in its NatA complex conﬁguration. (D) Chemical structure of the bisubstrate conjugate shown in (C), consisting of
acetyl-CoA (blue) covalently linked to a NatA substrate peptide fragment Ser-Ala-Ser-Glu-Ala. Brackets represent the
segment of the substrate peptide not crystallized and not shown in (C). The X-ray diffraction structures in (A–C) are modiﬁed
from protein data bank (PDB) entry: 4KVM [21].(Q/RxxGxG/A) ﬂanked by four /-helices and seven b-sheet segments [16,21,29,37,38]. The
acetyl-CoA binding domain is formed by several secondary elements (/3 and b2, b3, and b4)
[37]. Substrate binding and the catalytic bi-bi reaction occur in a semi-open cavity that harbors
both acetyl-CoA and the ﬁrst 4–5 amino acids of the N-terminal peptide (Figure 4B,C).Trends in Biochemical Sciences, September 2016, Vol. 41, No. 9 751
Substrate speciﬁcity is assured by an N-terminal helix-to-helix loop and a C-terminal b-hairpin
loop (Figure 4B) [21,37]. This C-terminal b-hairpin in NATs has an extended loop compared
to KATs of the same superfamily, restricting the substrate speciﬁcity to /-amino groups
[39,40]. Thus, these recent structural advances and enzymatic investigations reveal that it
is improbable that NATs can acetylate e-amino groups on lysine residues [39], as suggested
for Naa10 and other NATs by previous in vitro studies [41,42]. However, NATs may act as
N-terminal propionyltransferases, transferring slightly larger chemical groups onto protein
N-termini [43].
The structure of the highly selective Naa40 differs from Naa10 and Naa50. In this case the
substrate speciﬁcity-providing b-hairpin is ﬂipped away from the substrate-binding site, and in
compensation the /1-loop-/2 adopts a new conformation owing to an extended N-terminal
segment [29]. This unique conformation of the extended loop is also the reason for the selectivity
of Naa40. In contrast to Naa10, Naa50, and Naa60, which have the highest preference for
peptide residue one and decreasing selectivity towards the succeeding residues, Naa40
requires the ﬁrst four residues for substrate binding [21,29,37,38].
In the NatA complex, binding to Naa15 affects the conformation of the Naa10 /1-loop-/2,
which alters the substrate speciﬁcity of Naa10 from acidic N-termini towards S- or A-starting
(NatA-type) N-termini [14,21]. It is possible that future structural studies of NatB and NatC
complexes will show similar modulating effects by the large auxiliary subunits (Naa25, Naa35) on
their respective catalytic subunits.
To summarize, a majority of proteins receive an acetyl group at their N-terminus through the
enzymatic activity of several NATs (NatA to NatF in humans) acting on different subtypes of N-
termini. The NATs are often complexes in which a catalytic GNAT fold-containing enzyme (e.g.,
Naa10) is paired with a ribosome-binding subunit (e.g., Naa15), and the recently solved
structures reveal how auxiliary subunits may also modulate substrate speciﬁcity. Nt-acetylation
was recently connected to the organelles through the identiﬁcation of Golgi- and chloroplast-
resident NATs. The following section focuses on how the proteins subjected to Nt-acetylation
are affected at the molecular level.
Substrate Responses to the Nt-Acetyl Group
With the wide array of proteins undergoing Nt-acetylation, it is not surprising that the substrate
proteins are affected very differently (Figure 5). There are several examples of proteins that
crucially depend on the Nt-acetyl group for some part of their functioning. However, the overall
roles of Nt-acetylation are only recently beginning to emerge.
Nt-Acetylation of Cellular Proteins Affects Proteasomal Half-Life Regulation
A fundamental function of Nt-acetylation in promoting protein degradation was proposed in
2010 when it was shown that the acetyl group at the N-terminus of a protein can act as a speciﬁc
degradation signal (termed Ac/N-degron) that is targeted by the Ac/N-end rule pathway, a novel
branch of the previously characterized N-end rule pathway [44]. In this case, acetylated
N-termini starting with M, S, A, T, or V were identiﬁed as Ac/N-degrons, and Doa10 [44]
and Not4 [45] E3 ubiquitin ligases were described as speciﬁc recognition components
(Ac/N-recognins) of the Ac/N-end rule pathway (Figure 5-1). Recently, Ac/N-degrons were
described as conditional in that they may be shielded from recognition through participation in a
protein complex (Figure 5-2) [45]. This work also identiﬁed two Ac/N-degron-containing sub-
strates, Hcn1 and Cog1, which were each found to have their Ac/N-degron shielded upon
complex formation with Cut9 and Cog2/3, respectively. The acetylated N-terminal Met residue
of Hcn1 is enclosed within a TPR superhelix chamber in Cut9 [46]. This was the ﬁrst crystal
structure showing an Nt-acetylated Met at a protein–protein interaction site.752 Trends in Biochemical Sciences, September 2016, Vol. 41, No. 9
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Figure 5. N-Terminal Acetylation May Affect Proteins in Several Different ways. Summary of described examples of protein functional effects of Nt-acetylation.
NAT activity leads to an Nt-acetylated protein. This modiﬁed protein may be recognized by an Ac/N-recognin E3 ligase (e.g., Doa10) and targeted for proteasomal
degradation through the Ac/N-end rule pathway, in which case the acetylated N-terminus acts as an Ac/N-degron (1). Another fate of an Nt-acetylated protein may be
participation in a complex in which the Nt-acetyl group has a particular role in the protein–protein interaction site, acting as an interaction mediator (2). Complex formation
may also represent a way for newly correctly folded proteins to shield their Ac/N-degron and prevent Ac/N-end rule targeting. Nt-acetylation-dependent targeting to the
correct subcellular localization (3) may occur through protein–protein interactions or direct protein–membrane interactions; in the latter, the Nt-acetyl group possibly
stabilizes a membrane-interacting secondary structure, such as an N-terminal /-helix like in the case of /-synuclein. Another example of Nt-acetylation-dependent
targeting is the ﬁnding that acetylated N-termini prohibit post-translational import of proteins into the ER via the SRP-independent pathway using the Sec62 translocation
channel (4). Finally, NAT-depletion is also associated with protein aggregation, suggesting that Nt-acetylation is involved in global protein folding (5). Abbreviations: Ac,
acetyl group; ER, endoplasmic reticulum; NAT, N-terminal acetyltransferase; SRP, signal recognition particle; Ub, ubiquitin.Continued work on the Ac/N-end rule pathway demonstrated that it is complemented by
another branch of the N-end rule, the Arg/N-end rule pathway [47]. In this case Ubr1, the
ubiquitin ligase of the Arg/N-end rule pathway, was shown to recognize unacetylated Met if
followed by a bulky hydrophobic residue; that is, unacetylated NatC/E/F-type N-termini
(Figures 2 and 3). This means that both Nt-acetylation and lack thereof can target proteins
for degradation via the N-end rule pathway. A physiologically relevant example of such dual
targeting was later provided by a study on Rgs2, a regulator of mammalian G-protein signaling
[48]. The wild-type MQ-Rgs2 is subjected to degradation by the Ac/N-end rule pathway
subsequent to full NatB-mediated Nt-acetylation (i.e., all Rgs2 molecules are Nt-acetylated).
By contrast, a naturally occurring N-terminal mutant associated with hypertension, ML-Rgs2, is
only partially Nt-acetylated by NatC (i.e., both Nt-acetylated and un-Nt-acetylated variants of
Rgs2 are produced), and thus may be degraded via either of the two branches of the N-end rule.
Overall, this leads to the mutant having a shorter half-life. The result is an imbalance in signaling
governing blood pressure control in patients bearing that mutant, thus connecting the N-end rule
pathway and Nt-acetylation to human physiology [48,49].Trends in Biochemical Sciences, September 2016, Vol. 41, No. 9 753
The generalizability of the Ac/N-end rule is challenged by the fact that fewer than 10 proteins
have been demonstrated to follow this degradation pathway [44,45,47,48]. In addition, several
previously known substrates of an Ac/N-recognin, such as Doa10, do not appear to require Nt-
acetylation for their degradation [50], suggesting that Doa10, similarly to Ubr1 (the N-recognin of
the Arg/N-end rule pathway), may, in addition to the Ac/N-degron recognition site, also contain
other substrate-binding sites. Moreover, a more complex picture is suggested by studies
describing increased protein half-lives due to Nt-acetylation, such as the Drosophila Hyx [3]
and the human THOC7 [51].
Nt-Acetylation as a Mediator of Protein Interactions and Complex Formation
Complex formation may not only shield proteins from Nt/Ac-mediated degradation but may also
be involved in enhancing protein complex formation per se (Figure 5-2). For example, NatC-
mediated Nt-acetylation increases the afﬁnity of Ubc12 for Dcn1, and yeast and human crystal
structures revealed that Met-1 of the N-terminus of Ubc12 is buried in a hydrophobic pocket in
Dcn1 [52]. Later, this concept was expanded because this distinctive Nt-acetylation-dependent
interaction is structurally conserved across a family of mammalian NEDD8 ligation enzymes [53].
X-ray structures of Sir3 binding to the nucleosome revealed an Nt-acetylation-dependent inter-
action in which the Nt-acetyl group does not directly participate at the interaction site, but instead
stabilizes a binding loop [54,55]. Another Nt-acetylation-dependent interaction is exempliﬁed by
phosducin-like 3 (PDCL3), a chaperone involved in the regulation of vascular endothelial growth
factor receptor-2 (VEGFR-2). Interaction between these to proteins depends on NatB-mediated
Nt-acetylation of PDCL3 and results in VEGFR-2 protection from misfolding and aggregation [56].
Nt-Acetylation as a Determinant for Protein Subcellular Localization
Several examples in which Nt-acetylation acts as a localization determinant in yeast have been
known for some time [18,57,58]. However, despite more recent efforts [59,60], potential
additional yeast substrates depending on the Nt-Ac group for localization remain unknown.
Some of the examples of Nt-acetylation-dependent protein subcellular targeting (Figure 5-3)
occur through protein–protein interaction. However, a direct interaction between an Nt-acety-
lated protein and the membrane can be rationalized by the increased hydrophobicity of an
acetylated N-terminus (Figure 1) contributing to the overall hydrophobicity or stabilization of a
membrane-interacting region. A recent clinically relevant example is the Parkinson's disease-
implicated protein /-synuclein. Nt-acetylation stabilizes an N-terminal /-helix in /-synuclein,
which increases its afﬁnity for membranes [61]. Structural characterization further revealed an
Nt-Ac-/-synuclein–Cu(I) complex, in which Nt-acetylation as well as copper binding to the N-
terminal region contribute to stabilization of the /-helical structure [62]. The Nt-acetyl group likely
stabilizes the helix macrodipole and cause more favorable H-bonds as a result of the absence of
the /-amino positive charge. These recent reports on /-synuclein not only substantiate the link
between Nt-acetylation and targeting to membranes but also suggest a possible role of Nt-
acetylation in metallobiology.
Another mode of Nt-acetylation-dependent subcellular targeting was indicated by a study
demonstrating that the absence of Nt-acetyl groups is part of an early determining step in
the cellular sorting of nascent polypeptides following the signal recognition particle (SRP)-
independent pathway for post-translational translocation across the endoplasmic reticulum
(ER) membrane (Figure 5-4) [63]. In this case the N-termini of cytosolic proteins were reported to
typically be among the highly Nt-acetylated NAT substrate classes, NatA or NatB, as compared
to the N-termini of secretory proteins, which were typically enriched for NatC/E/F-type sequen-
ces. Moreover, mutating such secretory proteins into more Nt-acetylatable variants inhibited
their targeting to the ER. However, note that many of the proteins harboring secretory signal
sequences match the NatC/E/F-target class (Figure 2) meaning that they cannot per se be
considered as non-Nt-acetylated.754 Trends in Biochemical Sciences, September 2016, Vol. 41, No. 9
Nt-Acetylation Affecting Protein Folding and Aggregation
The presence or absence of charge at the N-terminus may be a central factor in protein folding.
Indeed, a potential role of Nt-acetylation in global protein folding (Figure 5-5) was recently
uncovered [64]. It was shown here that Nt-acetylation deﬁciency in NatA-deleted yeast leads to
the accumulation of misfolded proteins and increased levels of chaperones. This study also
suggested that NatA might be implicated in the Sup35/PSI+ prion cycle in yeast. Prions are
heritable elements transmitted via protein, typically ordered into ﬁlamentous aggregates (amy-
loids). In [PSI+] yeast cells the Sup35 protein forms amyloids. Sup35 is a NatA substrate, and
deletion of NatA in [PSI+] phenotypic cells decreases the stability of unacetylated Sup35 amyloid
and relieves the phenotype of the [PSI+] cells [64].
NatA depletion in human cells was also shown to cause aggregation of Huntingtin (Htt). HYPK
(Htt-interacting protein K) stably interacts with NatA (Figure 3A), which is essential for its optimal
Nt-acetylation activity [25]; HYPK also acts as a chaperone that prevents aggregation of Htt [65].
Knockdown of HYPK, but interestingly also Naa10 or Naa15, increases the aggregation
tendency of mutant polyQ Htt, which is found in patients with Huntington's disease [25]. Thus,
it appears that the NatA–HYPK complex is essential for proper Htt folding, possibly as a result of
the direct Nt-acetylation of Htt. Another example of disease-related aggregation that is con-
nected to Nt-acetylation is /-synuclein in Parkinson's disease, described above.
Interplay Between Nt-Acetylation and Other Protein Modiﬁcations
It was recently found that Ube2w, an E2 enzyme, can ubiquitylate the /-amino groups of protein
N-termini [66,67], whereas ubiquitylation more commonly occurs on the e-amino group of
lysines. These reports indicate the possibility of an interplay between E2s and NATs that both act
on protein N-termini, in which Nt-acetylation may potentially block E2s and ubiquityl-mediated
proteasomal degradation, or inhibit signaling events mediated by N-terminal monoubiquitylation.
Another example of such interplay with other modiﬁcations is the ﬁnding that NatD-mediated Nt-
acetylation of histone H4 blocks the methylation of H4Arg3, which in turn regulates ribosomal
DNA silencing [68]. A recent study also revealed kinetic competition between Naa50 and
MetAPs, and proposed that Naa50-mediated Nt-acetylation may act to retain the iMet of
otherwise MetAP-susceptible N-termini [69].
Several studies have now demonstrated the importance of Nt-acetylation for many different
proteins. The molecular mechanisms in which Nt-acetylation take part are diverse and encom-
pass half-life regulation, protein–protein and protein–membrane interactions, subcellular locali-
zation, folding, and aggregation. The following sections discuss the physiological consequences
of Nt-acetylation as revealed by recent studies on model organisms and human diseases.
Physiological Functions of NATs in Model Organisms
The consequences of Nt-acetylation are also manifested in biological systems, and studies using
different model organisms demonstrate NATs to be essential for a variety of physiological
processes (Figure 6). Speciﬁc links between organism phenotypes and molecular regulation
of or by NATs are now in the process of being uncovered.
In Arabidopsis, Nt-acetylation was recently shown to impact on drought-stress adaptation
because NatA-depleted plants have increased drought-tolerance (Figure 6A-1) [70]. In that
study, one of the very few known examples of upstream regulation of NAT activity was also
revealed. Wild-type plants subjected to drought stress were shown to have decreased Nt-
acetylation levels caused by a rapid transcriptional downregulation of NatA subunits by abscisic
acid, a plant stress hormone. The ﬁnding that NatA function is indispensable in Arabidopsis
supports its physiological importance, and overall this report suggests that decreases in NatA-
mediated Nt-acetylation is an important switch in cellular stress responses [70].Trends in Biochemical Sciences, September 2016, Vol. 41, No. 9 755
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Figure 6. Regulatory Consequences of NAT Activity at the Organism Level. (A) Impact of regulated Nt-acetylation in Arabidopsis. (A1) Under drought, plants
produce the phytohormone abscisic acid (ABA) that induce part of the drought-stress response through transcriptional regulation, allowing the plant to adapt to the
drought environment. As part of this process, ABA negatively affects the activity of NatA, causing a drought-responsive reduction in Nt-acetylation levels. Experimental
induction of NatA-depletion with the concomitant reduction in global Nt-acetylation triggers constitutive induction of the drought-stress response, thus pre-adapting
these plants to drought and increasing tolerance and survival, although NatA-depletion under normal water supply conditions causes vegetative growth retardation [70].
(A2) SNC1 is a Nod-like receptor serving as a immune receptor, and thus plays an important role in defense against pathogens in plants. Differential translation initiation
generates two Nt-variants: MMD-(SNC1) and MD-(SNC1), which are each subject to Nt-acetylation, but by different NATs and with different consequences. For the NatA
substrate, MMD-(SNC1), the Ac-Met likely acts as an Ac/N-degron, destabilizing SNC1 and thereby causing decreased pathogen tolerance. By contrast, the shorter MD-
SNC1 form is Nt-acetylated by NatB and stable, conferring increased immune resistance [71] (* indicates some uncertainty about which NAT actually performs Nt-Ac of
the MMD variant; see text). (B) Inﬂuence of NATs in C. elegans metabolism and development. (B1) The C. elegans lifespan and reproductive cycle consists of four larval
stages (L1–L4), adulthood, and a dormant larvae dauer stage that is induced by an unfavorable environment. daf-31/NAA10-mutated larvae do not adopt a proper dauer
stage under starved conditions. In addition, these daf-31/NAA10-mutated, starved larvae do not resume development upon exposure to nutrients [75]. (B2) Molecular
model of how NATs affect the pathway balancing dauer stage formation and growth, starting with the transmembrane receptor DAF-2. Naa10/NatA stimulates the activity
of DAF-16, a transcription factor regulating stress-response genes and whose inhibition by DAF-2 controls dauer formation. NatC acts further downstream in this
pathway because it is repressed by DAF-16. Under rich environmental conditions NatC negatively impacts on stress resistance and dauer formation [76].Another recent plant study identiﬁes Nt-acetylation as a key switch in immune regulation and
reports the antagonistic regulation of two different N-terminal variants of the same protein by two
NATs (Figure 6A-2) [71]. The key plant immunity protein, SNC1, exists as two Nt-variants, MD-
SNC1 (NatB substrate) and MMD-SNC1 (therein reported as a NatA substrate). Peculiarly, these756 Trends in Biochemical Sciences, September 2016, Vol. 41, No. 9
two variants respond very differently to Nt-acetylation: Ac-MMD-SNC1 is destabilized and Ac-
MD-SNC1 is stabilized, leading to a decreased or enhanced immune response, respectively.
Hence, this study connects protein half-life regulation by Nt-acetylation (discussed earlier) to
biological regulation, and also demonstrates how this may interplay with alternative Nt-variants
to provide homeostatic regulation. It can be speculated that such a two-faced regulation might
apply to other MM-starting proteins as well [71,72]. Note that MMD-SNC1 does not match the
canonical NatA speciﬁcity, and modiﬁcation could conceivably involve Naa50/NatE (Figure 3A).
Previous studies in Arabidopsis have identiﬁed phenotypes associated with NAT loss-of-func-
tion. Pleiotropic developmental defects were associated with loss of NatB activity as observed in
tcu2/NAA25-mutated plants [73]. In addition, NatC-mediated Nt-acetylation is necessary for
normal growth and efﬁcient photosynthesis, as revealed by the mak3-1/NAA30 mutant in which
the synthesis of two key photosynthetic proteins, D1 and CP47, is affected [74].
In Caenorhabditis elegans, Nt-acetylation has been linked to development and metabolism as
daf-31/NAA10 mutants failed to properly enter and exit the dauer stage, which is essential for
C. elegans survival during starvation (Figure 6B-1) [75]. These ﬁndings indicate that NatA plays
an important role in regulating adaptive metabolic behavior through an insulin-like IGF1
signaling pathway by inducing the activity of the transcription factor DAF-16. Interestingly,
the same pathway was found to involve NatC, acting as a modulator of stress resistance
downstream of DAF-16 [76]. In this case, loss-of-function mutations in natc-1/NAA35
increased resistance to several stressors, including oxidative stress. This study thus represents
another example where a NAT is both regulated by and a key regulatory factor in important (in
this case, metabolic) physiological processes. Such a metabolic involvement by NatC has also
previously been suggested by yeast nutrient stress studies (reviewed in [18]). NatC could also
possibly be linked to aging because a recent yeast study found this NAT to affect proteasome
distribution (an age-dependent process) and showed that loss of NatC speciﬁcally affects
growth of replicative old cells, in other words, those that have produced a high number of
daughter cells [77].
The involvement of Naa10 in development was also supported by a Drosophila melanogaster
study in which reduced Naa10 levels caused pleiotropic oogenesis defects [78]. Further, naa10-
null mutations were shown to affect cell growth and division, and caused lethality. Drosophila
ﬂies mutated in Naa50 (NatE) [24] and ﬂy cells depleted for Naa60 (NatF) [15] are viable, but have
phenotypes related to cellular chromatid cohesion.
The zebraﬁsh Danio rerio was recently adopted in NAT studies, and here the essentiality of
Naa10 for development was again demonstrated. Developmental abnormalities such as a bent
axis, abnormal eyes, and bent tails were observed after morpholino-mediated knockdown of
naa10 [79]. These morphants were further described to display increased lethality and growth
retardation. An earlier zebraﬁsh study also connected NatC to development, and embryonic
growth control and vessel development were affected, possibly through changes in mTOR
signaling [80]. The Nt-acetylation-dependent protein interaction between Ac-MQ-PDCL3 and
VEGFR-2 described above is associated with angiogenesis in zebraﬁsh and mice [56]. The same
report showed that a mutant PDCL3 that is unable to undergo Nt-acetylation was unresponsive
to hypoxia, a known stimulator of angiogenesis which normally regulates the expression of
PDCL3.
Overall, these organism-based studies undoubtedly testify that NATs play important physiolog-
ical roles in development, stress signaling, and metabolic adaptation, and they will no doubt
continue to provide important contributions to our understanding of the function of Nt-acetyla-
tion in humans.Trends in Biochemical Sciences, September 2016, Vol. 41, No. 9 757
Outstanding Questions
Are there more NAT enzymes to be
discovered in eukaryotes? Most of the
Nt-acetylome appears to be accounted
for by the known NATs. However, pro-
teomics and phylogenetic data indicate
that there may exist further so-far
unidentiﬁed NATs, for example in chlor-
oplasts and mitochondria.
How do NATs interact with ribosomes?
Are speciﬁc NATs targeted to distinct
ribosome populations? The distinct
ribosome-binding auxiliary subunits of
the different NATs may potentially
serve as adaptors for particular ribo-
some populations that speciﬁcally
translate the substrates of the different
NATs. Such a speciﬁc NAT–ribosome
system would facilitate rapid and efﬁ-
cient Nt-acetylation, avoiding poten-
tially time-consuming scanning events.
What are the biological functions of Nt-
acetylation, and how do they connect
to protein-level effects? Our under-
standing of the cellular as well as phys-
iological functions of Nt-acetylation is
still limited. Of particular interest is the
linkage of phenotypes observed in
model organisms and human diseases
to particular NAT substrates.
Is Nt-acetylation regulated? Plant
drought-stress-induced reduction of
Nt-acetylation via NAT-downregulation
was recently demonstrated. NAT reg-
ulation could also possibly occur
through enzyme activation or inactiva-
tion, directly via acetyl-CoA levels (as
for histone acetylation), or by reversibil-
ity of the modiﬁcation. Although it might
be unlikely that the majority of Nt-acet-
ylated proteins are Nt-deacetylated, it
is plausible that a few key proteins may
be deacetylated for speciﬁc regulatory
purposes.
Could speciﬁc inhibition or activation of
NATs be utilized in disease treatment?
Compounds speciﬁcally targeting
NATs are being developed, and such
compounds have potential in the treat-
ment of NAT-related diseases. In theImpact of NATs in Human Diseases
The importance of Nt-acetylation in human development and physiology has recently been
established through the discovery of NAT mutations in several pathological conditions. Various
mutations impairing the stability and/or catalytic activity of Naa10 are known to cause genetic
disorders. The lethal X-linked Odgen syndrome is caused by a Ser37Pro mutation in Naa10 that
impairs its catalytic activity as well as complex formation with Naa15 and Naa50 [51,81,82].
Other missense mutations in the NAA10 gene result in severe human disorders in both males
and females, including Tyr43Ser, Arg83Cys, Phe128Leu/Ile, Val107Phe, and Arg116Trp
[83–86]. These patients have partially overlapping phenotypes including global developmental
delay, cardiac anomalies, and intellectual disabilities.
A recent study connected Nt-acetylation with human blood pressure regulation by showing altered
NAT targeting and half-life (described earlier) for a hypertension-associated variant of Rgs2, a
blood pressure-regulating G-protein [48]. As described earlier, Nt-acetylation was also connected
to Parkinson's disease through /-synuclein [87,88], and to Huntington's disease through NatA
downregulation, leading to HYPK depletion and aggregation of the polyQ Huntingtin protein [25].
Several NATs, especially the NatA subunits, show an involvement in cancer cell survival and
proliferation. In particular, Naa10 is able to act both as oncoprotein and tumor suppressor,
depending on the type of tumor and tissue [89–92]. Other NATs are also involved in tumor
development, as shown by NAA30 knockdown experiments resulting in reduced tumorigenicity
in glioblastoma cells. The NAA30 knockdown cells had reduced levels of HIF1/ and increased
levels of the apoptosis factor p53 [93]. Similar effects were observed for Naa40, where NAA40
knockdown in colorectal carcinoma cells led to increased apoptosis by activation of the
mitochondrial caspase 9-mediated apoptotic cascade [94]. The manifold involvement of NATs
in various signal cascades important for tumor development and metastasis makes it challeng-
ing to generally summarize the impact of NAT on cancer. Nevertheless, this also encourages the
development of speciﬁc NAT inhibitors as potential new cancer drugs [33].
Concluding Remarks and Future Perspectives
The majority of proteins are acetylated at their N-terminus, and the identity of the ﬁrst two amino
acids can be used to predict whether your favorite protein is modiﬁed and by which N-terminal
acetyltransferase. With as much as 80% of the proteome being substrates for Nt-acetylation, the
work of understanding its functions is still ongoing. Our understanding of Nt-acetylation has
recently advanced signiﬁcantly. Protein features that may be affected by Nt-acetylation are half-
life, interaction ability, subcellular targeting, folding, and aggregation. In particular, the biological
consequences of NAT activities, which we knew nearly nothing about only a few years ago, are
now in the process of being elucidated. Several important roles for NATs in physiological
processes such as development, stress signaling, and metabolic adaptation have recently
emerged. However, we are still unable to answer the fundamental question of why the cell
spends vast amounts of energy on attaching acetyl moieties to the N-termini of so many proteins.
Part of this enigma may be resolved by upcoming future studies (see Outstanding Questions).
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